Portfolio company
Portal Biotech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
7 investors
Sectors
About
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Portal
The company develops portable protein sequencing devices for pharmaceutical researchers, clinicians, and defence agencies to identify pathogens and accelerate drug discovery.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Glyphic
This biotechnology company develops a protein sequencing platform for researchers to accelerate drug discovery and proteomic analysis.
Genetic Sequencing
This company develops nanopore-based technology for DNA sequencing to support researchers and clinicians in medical diagnostics and genomic analysis.
Seed, 2024
This company develops a single-molecule DNA sequencing platform for clinical diagnostics, agriculture, and biosecurity sectors.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Open Protein
This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.
